Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Leukemia

Showing results (1231-1240 of 9,628) with videos related to

Pageof 963
Sort By:
Leukemia|March 4, 2005
Purity for clarity: the need for purification of tumor cells in DNA microarray studiesD de Ridder, C E van der Linden, T Schonewille, et al.
Leukemia|March 4, 2005
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemiaF Pane, G Cimino, B Izzo, et al.
Leukemia|March 4, 2005
Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphomaT Fukushima, Y Miyazaki, S Honda, et al.
Leukemia|May 13, 2005
Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic diseaseO J Semmes, L H Cazares, M D Ward, et al.
Leukemia|November 13, 2004
Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cellsP Lunghi, A Tabilio, F Lo-Coco, et al.
Leukemia|November 13, 2004
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionG Gaipa, G Basso, O Maglia, et al.
Leukemia|January 1, 1992
Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosisL W Terstappen, M Safford, S Könemann, et al.
Leukemia|October 22, 2004
Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell supportF E Bertrand, J D Spengemen, J G Shelton, et al.
Leukemia|October 22, 2004
Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groupsT Cloppenborg, M Stanulla, M Zimmermann, et al.
Leukemia|October 22, 2004
KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)R L Levine, M Wadleigh, D W Sternberg, et al.
Pageof 963

Showing results (1231-1240 of 9,628) with videos related to

Sort By:
Pageof 963
Leukemia|March 4, 2005
Purity for clarity: the need for purification of tumor cells in DNA microarray studiesD de Ridder, C E van der Linden, T Schonewille, et al.
Leukemia|March 4, 2005
Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemiaF Pane, G Cimino, B Izzo, et al.
Leukemia|March 4, 2005
Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphomaT Fukushima, Y Miyazaki, S Honda, et al.
Leukemia|May 13, 2005
Discrete serum protein signatures discriminate between human retrovirus-associated hematologic and neurologic diseaseO J Semmes, L H Cazares, M D Ward, et al.
Leukemia|November 13, 2004
Arsenic trioxide (ATO) and MEK1 inhibition synergize to induce apoptosis in acute promyelocytic leukemia cellsP Lunghi, A Tabilio, F Lo-Coco, et al.
Leukemia|November 13, 2004
Drug-induced immunophenotypic modulation in childhood ALL: implications for minimal residual disease detectionG Gaipa, G Basso, O Maglia, et al.
Leukemia|January 1, 1992
Flow cytometric characterization of acute myeloid leukemia. Part II. Phenotypic heterogeneity at diagnosisL W Terstappen, M Safford, S Könemann, et al.
Leukemia|October 22, 2004
Inhibition of PI3K, mTOR and MEK signaling pathways promotes rapid apoptosis in B-lineage ALL in the presence of stromal cell supportF E Bertrand, J D Spengemen, J G Shelton, et al.
Leukemia|October 22, 2004
Immunosurveillance of childhood ALL: polymorphic interferon-gamma alleles are associated with age at diagnosis and clinical risk groupsT Cloppenborg, M Stanulla, M Zimmermann, et al.
Leukemia|October 22, 2004
KIAA1509 is a novel PDGFRB fusion partner in imatinib-responsive myeloproliferative disease associated with a t(5;14)(q33;q32)R L Levine, M Wadleigh, D W Sternberg, et al.
Pageof 963